We wish to inform you that the Board of Directors of the Company at their meeting held on 29.05.2026 has recommended a final dividend of Rs.2/- per equity share of face value of Rs.10/- ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Hannah Joseph Hospital Limited's Board approved audited FY2026 results showing strong performance with revenue from operations at Rs. 920.52 lakhs (up 18.7% from Rs. 775.31 lakhs in FY2025). Profit after tax grew 56.5% to Rs. 112.81 lakhs versus Rs. 72.10 lakhs. EPS improved to Rs. 6.32 from Rs. 4.32. The Board recommended a final dividend of Rs. 2 per share (20% on Rs. 10 face value), subject to shareholder approval. The company's auditor issued an unmodified opinion confirming clean financials. IPO proceeds of Rs. 4,200 lakhs were utilized with Rs. 753.29 lakhs spent primarily on capital expenditure (Rs. 70.80 lakhs for Radiation Oncology Centre) and issue expenses (Rs. 650.34 lakhs), with Rs. 3,446.71 lakhs remaining in fixed deposits.
Strong financial growth with 56% PAT increase and clean audit opinion are positive signals for shareholders. The dividend declaration provides immediate income benefit. The significant unutilized IPO funds (82% of proceeds) indicate capital is being deployed gradually for the Radiation Oncology project, suggesting future growth potential.